Suchergebnisse - "Kakavand, Hessam"

PubPharm (6)

1

Use of novel antithrombotic agents for COVID-19 : Systematic summary of ongoing randomized controlled trials

enthalten in: Journal of thrombosis and haemostasis : JTH | 2021

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +13

2

Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19 : JACC State-of-the-Art Review

enthalten in: Journal of the American College of Cardiology | 2021

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +20

UpdateOf: medRxiv. 2021 May 04;:. - PMID 33972948

3

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit : The INSPIRATION Randomized Clinical Trial

enthalten in: JAMA | 2021

von INSPIRATION Investigators | Sadeghipour, P. | Talasaz, A. | +77

CommentIn: JAMA. 2021 Apr 27;325(16):1613-1615. - PMID 33734290

4

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19 : JACC State-of-the-Art Review

enthalten in: Journal of the American College of Cardiology | 2021

von Talasaz, A. | Sadeghipour, P. | Kakavand, H. | +24

5

Cardiovascular Complications of COVID-19 : Pharmacotherapy Perspective

enthalten in: Cardiovascular drugs and therapy | 2021

von Talasaz, A. | Kakavand, H. | Van Tassell, B. | +4

6

Pharmacologic Prevention of Myocardial Ischemia-Reperfusion Injury in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

enthalten in: Journal of cardiovascular pharmacology | 2021

von Kakavand, H. | Aghakouchakzadeh, M. | Coons, J. | +1

CommentIn: J Cardiovasc Pharmacol. 2021 Apr 1;77(4):427-429. - PMID 33818549

1
[1]